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Abstract
Trypanosoma brucei, causing African sleeping-sickness, exploits quorum-sensing (QS) to
generate the ‘stumpy forms’ necessary for the parasite’s transmission to tsetse-flies. These
quiescent cells are generated by differentiation in the bloodstream from proliferative slender
forms. Using genome-wide RNAi selection we screened for repressors of transmission
stage-enriched mRNAs in slender forms, using the stumpy-elevated ESAG9 transcript as a
model. This identified REG9.1, whose RNAi-silencing alleviated ESAG9 repression in slen-
der forms and tsetse-midgut procyclic forms. Interestingly, trypanosome surface protein
Family 5 and Family 7 mRNAs were also elevated, which, like ESAG9, are T. brucei specific
and stumpy-enriched. We suggest these contribute to the distinct transmission biology and
vector tropism of T. brucei from other African trypanosome species. As well as surface fam-
ily regulation, REG9.1-depletion generated QS-independent development to stumpy forms
in vivo, whereas REG9.1 overexpression in bloodstream forms potentiated spontaneous dif-
ferentiation to procyclic forms in the absence of an external signal. Combined, this identifies
REG9.1 as a regulator of developmental cell fate, controlling the expression of Trypano-
soma brucei-specific molecules elevated during transmission.
Author summary
African trypanosomes cause important disease of humans and livestock in sub Saharan
Africa and are transmitted by tsetse flies. In preparation for transmission, Trypanosoma
brucei uses quorum sensing to generate ‘stumpy forms’ that are arrested and express a dis-
tinct subset of genes to the ‘slender forms’ that proliferate to establish the parasitaemia in
the bloodstream. This necessitates that stumpy-enriched transcripts are repressed in slen-
der forms, although the molecular control of this is unknown. Here, we have developed a
genome-wide selectional strategy to isolate repressors of stumpy-enriched genes, and
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successfully identified a novel regulatory molecule, termed REG9.1. Silencing of REG9.1
alleviates the repression of the previously characterised stumpy-enriched ESAG9 gene
family, and also two novel predicted surface protein families that are specific to Trypan-
soma brucei but absent from other African trypanosome species. REG9.1 silencing also
drives density-independent differentiation to stumpy forms, whereas its ectopic expres-
sion in bloodstream forms potentiates differentiation to tsetse midgut procyclic forms in
the absence of an external signal. REG9.1 is therefore identified as a novel developmental
regulator whose action may contribute to the species-specific transmission biology of Try-
panosoma brucei, which differs from that of either Trypanosoma congolense or Trypano-
soma vivax.
Introduction
African trypanosomes comprise a collection of different species (Trypanosoma brucei spp., Try-
panosoma congolense, Trypanosoma vivax) that differ in their host range, pathology, morphol-
ogy, motility and life-cycle development [1, 2]. These unicellular parasites, responsible for
Human and Animal African Trypanosomiasis (HAT, AAT), are highly unusual in the eukar-
yota in that their genome is organised into polycistronic gene clusters in which distinct genes
can show differential regulation either at the level of transcript abundance, translation or pro-
tein turnover [3].
Regulation of trypanosome gene expression is particularly important as these parasites
progress through their complex life cycle [4]. For T. congolense, development is limited to the
tsetse midgut and mouthparts, whereas for T. vivax the parasites are restricted to the mouth-
parts alone. In T. brucei, in contrast, there are several developmental forms both in the
bloodstream of their mammalian host and in different compartments of the tsetse fly [5, 6].
Specifically, the parasites proliferate in the tsetse fly midgut as early and late stage procyclic
forms before migration to the salivary glands where they establish as epimastigotes before
developing the metacyclic forms that are mammal infective [7]. Progression through these
developmental forms can be driven by the overexpression of just a single predicted RNA bind-
ing protein, RBP6, that allows the production of infective metacyclic forms from procyclic
forms without an external stimulus [8]. In the bloodstream, T. brucei establish the parasitaemia
as proliferative slender forms, which evade the host immune response through their expression
and ability to change the expression of a dense variant-specific surface glycoprotein (VSG)
coat [9–11]. As bloodstream parasite density increases, the trypanosomes exhibit a quorum-
sensing like response whereupon they arrest in G1 as a quiescent and morphological ‘stumpy
form’ [12]. These are competent for transmission to the tsetse fly upon their uptake in a blood-
meal where they differentiate to procyclic forms, whereas the bloodstream slender forms are
killed [13]. Hence, whilst sharing the same bloodstream environment as slender forms, the
stumpy form represents a distinct developmental stage, which also exhibits a distinct develop-
mental gene expression profile [14–17]. This requires regulators that either actively maintain
the slender cell form, or inhibit or promote the differentiation to stumpy forms.
Among the most predominant gene families up-regulated in stumpy forms is the ESAG9
gene family [14, 18]. ESAGs (Expression Site Associated Genes) are commonly found in the
polycistronic expression site locus responsible for VSG gene transcription. However, ESAG9
genes are only occasional components of the VSG gene expression sites and several copies
of the highly diverse gene family can be simultaneously expressed upon differentiation to
stumpy forms [18–20]. An analysis of the predicted cell surface phylome of different African
Trypanosome developmental control
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trypanosome species determined that ESAG9 genes (included in cell surface phylome Family
2) were specific to T. brucei and missing in the related parasites T. congolense and T. vivax [21].
This was also the case for eight other cell surface phylome families, which may have functions
related to the particular biology of T. brucei in their mammalian host or tsetse fly vector.
The stumpy-enriched expression of the ESAG9 gene family is regulated through their
3’UTR [22]. Exploiting this, here we report a genome-wide RNAi selectional regimen designed
to isolate repressors of stumpy-enriched gene expression operative in proliferative blood-
stream slender forms. This successfully identified several negative regulators, including one
(REG9.1; REGulator of ESAG9) whose independent depletion confirmed its function as a gen-
eral regulator of ESAG9 family gene expression. Strikingly, depletion of this molecule also
resulted in premature, density-independent, differentiation to stumpy forms in vivo and the
strong upregulation of members of the T. brucei cell surface protein families 5 and 7, in addi-
tion to ESAG9. Each of these gene families is absent in T. congolense and T. vivax. Interestingly,
ectopic expression of REG9.1 at the elevated levels normally observed in procyclic forms, also
caused bloodstream forms to elevate procyclic form surface protein mRNAs and potentiated
differentiation to that form. This identifies REG9.1 as a novel differentiation regulator and
controller of the surface molecules associated with the species-specific developmental biology
of T. brucei.
Results
A genome wide RNAi screen for repressors of molecules expressed in
the T. brucei transmission stage
Using genome-wide RNAi selection we sought to identify molecules that act in T. brucei slen-
der forms to repress stumpy form enriched mRNAs. Our strategy was to generate a cell line
that allowed us to select for increased resistance to G418 resulting from the loss of a repressor
that acted on a NeoR gene regulated by the expression control signals of a stumpy-enriched
transcript, ESAG9 (Fig 1A). Genome-wide screens require use of the s427 monomorphic
bloodstream form cell line, competent for efficient transfection with a tetracycline-inducible
RNAi library [23–26]. These cells, like slender forms in natural (pleomorphic) bloodstream
infections, express little ESAG9 mRNA due to posttranscriptional repression [18, 22]. To carry
out the screen, we initially transfected the s427 monomorphic parental cell line with a con-
struct comprising the neomycin resistance (NeoR) gene flanked downstream by a 1057nt frag-
ment containing the previously characterised 3’UTR control signals and intergenic sequence
of the ESAG9 gene Tb927.5.4620 [22] (‘ESAG9-EQ long 3’UTR’ in Fig 1A). When the resulting
cell line was assayed with a titration of G418, cells transfected with the NeoR gene coupled to
the ESAG9 flanking sequence were killed at10μg/ml G418, whereas cells transfected with the
same construct but where the NeoR gene was flanked by the constitutively-expressed aldolase
gene 3’UTR were viable at>750μg/ml G418 (Fig 1B). This confirmed our previous analyses
demonstrating that the ESAG9 downstream sequences repress gene expression in proliferative
slender forms [22].
The cell line with the construct comprising the NeoR gene flanked by the ESAG9 intergenic
sequence was then stably transfected with the tetracycline inducible genome-wide RNAi
library [25]. Thereafter, uninduced and induced populations were selected with 10μg/ml G418
(Fig 1C); eventual outgrowth of surviving cells occurred at 10μg/ml G418 with RNAi induction
but not at 25μg/ml G418. In contrast, in the absence of G418 or tetracycline, growth was main-
tained unimpeded through the duration of the experiment (Fig 1C). After genomic DNA isola-
tion and analysis of the RNAi insert amplicons from parasites throughout the selection period,
Trypanosome developmental control
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Fig 1. Selection of negative regulators of stumpy enriched transcript expression. A. Schematic representation of the selection schema to isolate
negative regulators of ESAG9 expression in slender forms; NR denotes a negative regulator. The selection construct used to transfect the RNAi library is
shown beneath. The NeoR gene is flanked by the 5’UTR of the trypanosome aldolase gene, whilst the 3’UTR is derived from 1057bp downstream of the
ESAG9-EQ stop codon (long form reporter, blue). B. Titration of the sensitivity of trypanosome lines with NeoR flanked by either the ESAG9-EQ 3’UTR or
aldolase 3’UTR. Error bars symbolize standard deviations of biological triplicates. C. RNAi library selection of parasites containing NeoR flanked by the
ESAG9 3’UTR (diamonds). The right hand panel shows the library insert amplicon profile from cells with NeoR flanked by the ESAG9 3’UTR at different
stages of selection in G418 when RNAi was either induced, or not. The gel shows gDNA isolated from untreated (no tetracycline, no G418) parasites at
days 2 and 3 (as a control), and treated parasites at days 11 and 14 after exposure to 1μg/ml of tetracycline and 10μg/ml G418, when parasites were
Trypanosome developmental control
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a significant change in the amplicon profile was observed with strong enrichment of discrete
bands after selection for 11 and 14 days in G418 (Fig 1C, right hand panel).
To analyse the selected material in detail, ion torrent deep sequencing [12] was carried out
on replicate samples of the day 14 selected populations. The resulting reads were mapped
against the T. brucei v9 genome assembly (Fig 1D; S1 Table) and the top 30 enriched loci ana-
lysed for alignment to genes with a predicted role in mRNA regulation. This identified three
candidate genes, of which two were already characterised to some extent (Tb927.6.3480,
DRBD5,[27]; Tb927.3.720, TbZFP3; [28, 29]) and a novel gene encoding a hypothetical protein
(REGulator of ESAG9-1, REG9.1; Tb927.11.14220) (Fig 1D). To verify the screen outputs, inde-
pendent RNAi constructs derived from each candidate gene were then transfected into the
monomorphic reporter cell line containing the NeoR gene flanked by the ESAG9 intergenic
region. NeoR protein expression was increased upon silencing of each potential regulator, vali-
dating the selection of each candidate, but RNAi targeting DRBD5 and ZFP3 did not elevate
endogenous ESAG9 transcript (S1 Fig). In the case of DRDB5, this was because the 5’UTR of
ESAG9 contributes to ESAG9 repression in addition to the 3’UTR (Rico and Matthews, per-
sonal observations). In contrast, REG9.1 knockdown (Fig 2A) resulted in enhanced G418
resistance (Fig 2B), elevation of NeoR mRNA (Fig 2C) and protein (Fig 2D), and elevation of
endogenous ESAG9-EQ transcripts (Fig 2E) in monomorphic cells.
To explore the regulation of the ESAG9-EQ mRNA further, REG9.1 RNAi was carried out
in reporter lines harbouring ESAG9-EQ downstream sequences extending only 400 nt from
the stop codon (ESAG9-‘short form’), or lacking a previously mapped regulatory element con-
tributing to stumpy-enriched expression (ESAG9 ΔE)(S2A Fig). The ESAG9-short form 3’UTR
was less sensitive to G418 than the control reporter with 1057 nt of downstream sequence,
consistent with the deletion of repressive elements from the 3’UTR (S2B Fig). Nonetheless
upon REG9.1 depletion, both the short form 3’UTR and the ΔE mutant exhibited increased
NeoR mRNA, demonstrating the retention of REG9.1-dependent regulatory motifs within
each 3’UTR (S2C and S2D Fig). Thus, REG9.1 negatively regulates ESAG9 through down-
stream sequences, but this was not simply restricted to discrete proximal or distal sequences in
the ESAG9 intergenic region, nor a small region of the 3’UTR.
Independent RNAi lines for 10 potential further targets identified in the library screen were
also generated but these either exhibited no effective RNA knockdown, did not enhance G418
resistance upon RNAi or generated a strong growth phenotype precluding informative follow-
up studies (S1 Table).
REG9.1 is differentially expressed
REG9.1 is predicted to encode a 54.4kDa protein with an acidic PI (pH 5.5) and a predicted
RNA-binding motif (Superfamily SSF54928 domain)(Fig 3A). In a previous mRNA tethering
screen, direct binding in parasites of a REG9.1-lambda N fusion protein to a reporter construct
mRNA with BoxB binding sites repressed expression, supporting a potential regulatory func-
tion for REG9.1 [27].
An antibody was generated against the REG9.1 protein and the developmental expression
profile of the protein assessed in pleomorphic slender and stumpy forms, and cultured insect
procyclic forms (Fig 3B). In addition to a band at 54 kDa, which was inconsistently detected,
two bands were detected at 57kDa and 59kDa potentially representing different post-
outgrowing as a resistant population. D. Genome-wide distribution of selected RNAi inserts determined by ion torrent sequencing, vertical dashes
representing the boundaries of each chromosome (with Chromosome 1 at the left). Targets highlighted comprise those with a high enrichment in the
selected population and a predicted RNA binding domain. The full dataset is available in S1 Table.
https://doi.org/10.1371/journal.ppat.1006279.g001
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Fig 2. Validation of RNAi lines silencing REG9.1 selected from the RNAi library. A. Northern blot
demonstrating the inducible gene silencing of REG9.1. Two independent RNAi clones were analysed
(REG9.1, clone 3 and 4).); rRNA was used as a loading control. Smearing is caused by the transcript being
larger than 6 kb. B. G418 resistance (at 10μg/ml) of the respective RNAi clones when RNAi was induced or
not. RNAi resulted in decreased sensitivity to G418. Error bars (obscured by the symbols) symbolize standard
deviations of the triplicate assays of each clone ±tetracycline. C. Northern blot of NeoR transcript levels when
Trypanosome developmental control
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translationally modified forms of the protein (Fig 3B). The upper band was somewhat less
abundant in stumpy forms compared to slender and procyclic forms, and in procyclic forms
the overall abundance of both 57 and 59 kDa bands was greater than in either bloodstream
form. Consistent with this, quantitative proteomic analysis has previously indicated that
REG9.1 is 2- [17] to 3-fold [30] more abundant in procyclic forms vs. stumpy forms.
To further explore the function of REG9.1, pleomorphic cell lines were generated that either
silenced this gene by RNAi or inducibly overexpressed the protein using the pLEW ectopic
expression vector [31]. Pleomorphic cells are considerably more difficult to analyse and geneti-
cally manipulate than laboratory adapted monomorphic lines but are necessary for develop-
mental studies since they undergo natural progression to stumpy forms, which is associated
with physiological ESAG9 regulation. Fig 3C shows northern analysis of two independent pleo-
morphic RNAi replicates demonstrating effective depletion of REG9.1. Matching the original
selection in monomorphic cells, in both cases, REG9.1 depletion caused upregulation of
ESAG9-EQ mRNA in vitro. In separate samples, the protein levels of REG9.1 were also corre-
spondingly reduced upon RNAi (Fig 3D).
To assess the phenotype resulting from REG9.1 depletion in vivo, the pleomorphic RNAi
line was inoculated into mice, with gene silencing being induced by provision of doxycycline
to the drinking water of replicate infected animals 1-day post infection. Strikingly, this resulted
in a rapid cessation of the increasing parasitaemia such that induced parasites remained below
5x107 parasites/ml compared to uninduced parasites that reached 2.5x108 parasites/ml (Fig
4A). Despite their low parasitaemia, the morphology of the induced parasites resembled inter-
mediate/stumpy forms generated by uninduced parasites at high parasitaemia after 4 days of
infection (Fig 4B; S3A Fig). To determine whether these had the expected physiological charac-
teristics of stumpy forms, we tested their cell cycle arrest in G0/G1, their expression of the
stumpy specific marker protein PAD1 [32] and their capacity for differentiation to procyclic
forms upon harvest and exposure in culture to 6mM cis aconitate. Fig 4C shows that the
induced parasites accumulated with a 1 kinetoplast 1 nucleus configuration (consistent with
G1/G0 arrest) and expressed PAD1 as assessed by both flow cytometry and western blotting
(Fig 4D), despite being at 5-10-fold lower cell density than uninduced parasites. Further, the
isolated parasites were able to differentiate synchronously to procyclic forms, expressing the
procyclic form surface protein EP procyclin on>60% of cells 4h after exposure to 6mM cis
aconitate (Fig 4E). The cells also re-entered a proliferative cell cycle after 24 h in these differen-
tiation conditions (S3B Fig). All of these assays demonstrated that REG9.1 depletion drives
cells to generate physiologically valid stumpy forms at much lower parasitaemia than when
uninduced, overriding normal quorum sensing mechanisms.
REG9.1 regulates mRNAs for developmentally regulated cell surface
proteins
The wider consequences for the parasites’ transcriptome of silencing REG9.1were then exam-
ined. Thus, in vitro grown biological replicates of the pleomorphic RNAi line, induced or not
for 48h, were analysed by RNA-seq (Fig 5; S2 Table). Fig 5A and 5B demonstrate that not only
ESAG9-EQ showed elevated expression but also many other members of the ESAG9 family
(lilac squares in Fig 5A; Green bars in Fig 5B), including those with only distant relationship to
each REG9.1 RNAi line was induced or not; rRNA was used as a loading control. D. Western blot of NeoR
protein when each REG9.1 RNAi line was induced or not; EF1αwas used as a loading control. E. Northern
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Fig 3. REG9.1 developmental expression profile and REG9.1 RNAi in pleomorphic parasites. A.
Schematic representation of REG9.1 showing the position of its single predicted RNA binding domain (RBD).
B. Protein expression of REG9.1. The antibody detects three bands, the lower band being detected
inconsistently between blots. The abundance of the two upper bands differ in different life cycle stages, with
the uppermost band being less abundant in stumpy forms. Procyclic forms express more REG9.1 than
bloodstream forms. C. Northern blot for REG9.1 and ESAG9-EQ in the parental line (T. brucei AnTat90:13) or
Trypanosome developmental control
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ESAG9-EQ, demonstrating co-regulation of the family. Interestingly, members of other gene
families were also elevated and coregulated with ESAG9 upon REG9.1 depletion. This included
members of the cell surface phylome Family 5 (red squares, Fig 5A) and Family 7 (blue squares,
Fig 5A) both of which, like ESAG9, are restricted to T. brucei, being absent from the genomes of
T. congolense or T. vivax [21]. Family 5 has 8 members, of which 5 were elevated upon REG9.1
depletion (Fig 5B, red bars); Family 7 comprises 9 members of which 6 were> log2FC elevated
in the absence of REG9.1 (Fig 5B, blue bars). Northern analysis using riboprobes simultaneously
detecting several members of these surface protein family mRNAs demonstrated their elevated
expression in stumpy forms, matching the expression profile of ESAG9 (Fig 5C). Hence REG9.1
acts as a negative regulator of at least three T. brucei specific surface protein families each of
which is expressed in the parasite’s transmission stage. Apart from these families, other upregu-
lated transcripts also encoded predicted surface proteins (e.g. MSP-A, Gp63; Fig 5A and Fig
5C), whereas down-regulated transcripts were related to cell proliferation and structure (e.g.
histones, flagellar and paraflagellar rod proteins) (Fig 5A). Transcripts for the PAD proteins,
diagnostic for stumpy forms, were not significantly regulated (S2 Table).
To investigate whether the transcript regulation observed simply represented a conse-
quence of the REG9.1 RNAi cells developing toward a stumpy phenotype and thereby upregu-
lating stumpy-enriched transcripts, we analysed REG9.1-depletion in procyclic forms, which
do not normally express ESAG9 transcripts. Thus, the uninduced pleomorphic bloodstream
form REG9.1 RNAi line was differentiated with 6mM cis aconitate and, once stably established
as procyclic forms, REG9.1 depletion was induced with tetracycline. The induced cells main-
tained growth, albeit at a reduced level compared to uninduced cells (Fig 6A), and the cells
appeared elongated and the population contained many anucleate cytoplasts (zoids; [33]) (Fig
6B). Western blotting confirmed that the REG9.1 protein was effectively depleted in the
induced population (Fig 6C), where many of the cells also showed severely reduced motility,
accumulating at the bottom of the culture flask, contrasting with the uninduced population
that remained distributed throughout the medium (S1 and S2 Supplementary data). Nonethe-
less, when RNA was analysed in the induced populations, ESAG9-EQ transcripts were found
to be upregulated (and to a limited extent in uninduced cells where REG9.1 RNAi was some-
what leaky), consistent with the observations in bloodstream forms. This eliminated the regu-
lation of these mRNAs in bloodstream forms being a simple indirect consequence of induced
stumpy formation and further supported a function for REG9.1 in the repression of stumpy-
enriched mRNAs regardless of life cycle stage.
Ectopic overexpression of REG9.1 potentiates differentiation to procyclic
forms
To assess whether an elevation of REG9.1 levels generated converse regulatory effects to that of
RNAi, and so delayed stumpy formation, pleomorphic bloodstream cells were generated that
were able to overexpress REG9.1. Supporting the physiological relevance of the REG9.1 ectopic
expression generated, the level of REG9.1 protein in bloodstream forms generated using the
pLEW expression vector was equivalent to the level normally seen in procyclic forms (Fig 7A).
The induced bloodstream form parasites remained viable and continued to proliferate, albeit
at a slightly reduced level (Fig 7B). However, analysis of the global transcriptome dataset for
two replicates of the pleomorphic RNAi lines induced or not to silence REG9.1. Smearing is caused by the
REG9.1 transcript being larger than 6 kb. rRNA provides the loading control. ESAG9-EQ mRNA is elevated
upon REG9.1 depletion in each replicate. D. Western blot of REG9.1 expression in pleomorphic cells induced
to deplete expression via RNAi. The loading control was an antibody detecting EF1α.
https://doi.org/10.1371/journal.ppat.1006279.g003
Trypanosome developmental control
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Fig 4. Phenotype of REG9.1 gene silencing in vivo. A. Growth of REG9.1 pleomorphic RNAi lines in vivo, with RNAi induced or not by doxycycline.
The inset shows the respective abundance of REG9.1 transcript in each case after cells were harvested on day 4 post infection and RNA prepared.
Two mice replicates (R1 and R2) were used for each condition (–DOX and +DOX). B. Morphology of cells on day 4 of infection. Two cells are shown for
the uninduced population, both being ‘intermediate’ in morphology, although the upper cell is somewhat more stumpy with the nucleus more proximal
to the kinetoplast; in the induced population a stumpy cell is shown, with the nucleus moved toward the cell posterior. Hence although at a much lower
parasitaemia (see panel A), the stumpy morphology of induced cells was equivalent to, or greater than, uninduced cells. The DAPI panel at the left
hand side shows the positions of the nucleus (N) and kinetoplast (K) in each case Bar = 10μm. C. Cell cycle profile of pleomorphic RNAi lines (R1, R2)
induced or not to silence REG9.1 expression. The kinetoplast/nuclear configuration was assessed on day 3 and day 4 of infection, with the associated
parasitaemia shown above each bar. At least 250 cells were counted for each condition/replicate/day. D. PAD1 expression profile determined by flow
cytometry in the REG9.1 RNAi lines (R1, R2) induced or not, with slender or stumpy T. brucei AnTat1.1 cells as controls. The parasitaemia of each
population at harvest is shown. PAD positivity was determined by gating with respect to the Slender (negative) and Stumpy (positive) control samples.
Below the chart is the PAD1 expression profile determined by western blotting in the REG9.1 RNAi lines (R1, R2) induced or not, when harvested, with
stumpy AnTat1.1 cells as control (‘ST’). EF1α abundance was used as a loading control. E. Flow cytometry of the expression of EP procyclin during
differentiation to procyclic forms of each REG9.1 RNAi line (R1, R2) 0h, 4h and 24h after exposure to 6mM cis aconitate. EP procyclin expression on
slender, stumpy and procyclic forms provide controls. A low level of EP procyclin expression is detected on stumpy cells, this being induced during
isolation and cell preparation procedures. Although at lower parasitaemia (panel A) the induced cells differentiate as effectively as uninduced cells
demonstrating the physiological relevance of the stumpy forms generated.
https://doi.org/10.1371/journal.ppat.1006279.g004
Trypanosome developmental control
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REG9.1 overexpression did not generate the opposite regulatory profile to RNAi. Rather, in
this case bloodstream-enriched mRNAs were downregulated and procyclic-form enriched
transcripts were elevated, particularly those encoding the procyclic form surface proteins EP
and GPEET procyclin (S3 Table; Fig 7C). This suggested a shift to a procyclic form-like tran-
scriptome profile upon REG9.1 overexpression. To determine if this was also reflected at the
protein level, bloodstream forms overexpressing REG9.1 were analysed for EP procyclin
expression by immunofluorescence microscopy. (Fig 8A and 8B, 0h) demonstrate that ~20%
of cells in the pleomorphic bloodstream form culture induced for 24h to overexpress REG9.1
spontaneously expressed EP procyclin without exposure to the normal differentiation trigger,
cis aconitate, whereas no cells with this phenotype were observed in uninduced cultures.
When transferred to procyclic form culture media, the proportion of procyclic form cells
progressively increased consistent with either further differentiation to procyclic forms
with continued culture, or the viable outgrowth of the differentiated population (S4 Fig). The
ability of REG9.1 to potentiate differentiation was not simply restricted to a founder popula-
tion however; when bloodstream forms induced to overexpress REG9.1 were exposed to the
Fig 5. Global transcriptome changes associated with REG9.1 RNAi. A. Transcripts up and down regulated upon REG9.1 RNAi in pleomorphic
trypanosomes. The data represents an analysis of biological replicates whether cells were induced or not to deplete REG9.1 (two replicates each). The
down regulation of histones and the upregulation of key regulated molecules, including ESAG9 (lilac), Family 5 (red) and Family 7 members (blue) is
highlighted. B. Relative LogFC (Log2 fold change) expression of different members of T. brucei surface protein Family 5 (red) Family 7 (blue) and
ESAG9 (green) after REG9.1 depletion by RNAi. C. Northern blots of ESAG9, Family 5 and family 7 transcripts in slender (SL), stumpy (ST) and
procyclic forms (PF). The similarity within family 5 and 7 results in the detection of multiple family members by the riboprobes, generating a smear of
bands. Northerns for GP63 and RHS7 are also shown, both being upregulated in the RNA-seq dataset. rRNA provides the loading control.
https://doi.org/10.1371/journal.ppat.1006279.g005
Trypanosome developmental control
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006279 March 23, 2017 11 / 25
Fig 6. REG9.1 RNAi in procyclic forms. A. Growth of procyclic form AnTat1.1 90:13 RNAi lines induced and uninduced to
deplete REG9.1. B. Morphology of T. brucei AnTat 90:13 procyclic form REG9.1 RNAi lines, induced and uninduced. DAPI
stained and phase-contrast/DAPI stained cells (‘Merge’) are shown. Bar = 10μm. C. On the left panel is shown a Western blot of
REG9.1 in AnTat1.1 90:13 procyclic forms whether induced or not to deplete REG9.1 transcript by RNAi for 96 h. Established T.
brucei AnTat 29:13 procyclic forms were used as a control; the loading control was an antibody detecting EF1α. On the right are
northern blots of REG9.1 and ESAG9-EQ mRNAs in stumpy forms, procyclic AnTat1.1 29:13 control cells and the AnTat1.1 90:13
Trypanosome developmental control
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differentiation trigger cis aconitate, 60% of cells expressed EP procyclin within 4 hours, con-
trasting with less than 20% in uninduced cultures (p<0.05; Fig 8B). This demonstrated that
they showed enhanced differentiation-competence. Thus, depletion of REG9.1 promotes the
differentiation to a stumpy form transcriptome profile, whereas its overexpression potentiates
differentiation to procyclic forms.
REG9.1 exhibits a differential cellular location in stumpy forms
Given the differential regulation by REG9.1 of stumpy-enriched transcripts, yet similar expres-
sion in slender and stumpy forms, we analysed the cellular distribution of REG9.1 in different
developmental forms by immunofluorescence. Fig 9A demonstrates that in slender and pro-
cyclic forms REG9.1 was distributed throughout the cell body, consistent with a cytoplasmic
location, although some flagellar staining was also observed in slender forms. In contrast, in all
stumpy cells examined there was a concentration of signal close to the flagellar pocket of the
cell, and also close to the cell flagellum (Fig 9A, arrowed). Co-staining of the cells with AMCA
which stains the cell surface and flagellar pocket demonstrated that the REG9.1 signal was only
partly overlapping with the flagellar pocket (Fig 9B) and ‘no first antibody’ controls confirmed
procyclic form REG9.1 RNAi line. Upon REG9.1 depletion (for 48h), ESAG9-EQ levels are elevated. Smearing for REG9.1 is
caused by the transcript being larger than 6 kb.
https://doi.org/10.1371/journal.ppat.1006279.g006
Fig 7. Pleomorphic trypanosomes expressing REG9.1 ectopically using pLEW express procyclic form mRNAs. A. Ectopic overexpression of
REG9.1 in pleomorphic bloodstream forms. The panel shows the expressed REG9.1 detected with an antibody to the protein in bloodstream forms
(induced or uninduced for overexpression using pLEW), with procyclic form (PF) samples included to demonstrate that similar levels of expression to
procyclic forms were generated upon induction. B. In vitro growth of parasites induced to express REG9.1 from the pLEW expression vector. C.
Transcripts up and down regulated upon REG9.1 ectopic expression using pLEW in pleomorphic trypanosomes. The data represents an analysis of
two biological replicates whether cells were induced or not to ectopically express REG9.1.
https://doi.org/10.1371/journal.ppat.1006279.g007
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the signal was not caused by secondary antibody recognition of host antibodies in the flagellar
pocket. Since REG9.1 has been detected in procyclic form stress granules by proteomic analy-
sis [34], we explored whether REG9.1 coalesced from its uniform cytoplasmic distribution in
procyclic forms to discrete foci upon starvation or heat shock. Under starvation conditions (2h
in PBS) REG9.1 co-localised partially with the stress granule marker Scd6 [35] (S5A Fig), but
this was not evident with heat shock, where Scd6 signal was also not obvious. Interestingly,
however, 20–25% of the heat shocked procyclic cells (and a smaller percentage of the starved
cells) showed a concentration of REG9.1 close to the flagellar pocket, similar to that observed
in stumpy forms (S5B Fig).
Fig 8. Ectopic expression of REG9.1 in pleomorphic trypanosomes potentiates differentiation. A. Immunofluorescence showing EP procyclin
expression on pleomorphic parasites induced to express REG9.1 ectopically using pLEW. αVSG AnTat1.1 is used as a marker of the bloodstream forms
surface. B. Flow cytometry showing EP procyclin expression on pleomorphic slender parasites induced to express REG9.1 ectopically using pLEW. 24h
after induction parasites were resuspended in procyclic form culture medium (SDM79) and induced to form procyclic forms in the presence of cis aconitate
(+CCA). Induced cells differentiated faster than the uninduced (**, P<0.01; ***, P<0.001).
https://doi.org/10.1371/journal.ppat.1006279.g008
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In summary, our genome wide analysis for regulators of stumpy-enriched gene expression
has identified REG9.1 as a novel key regulator of development in Trypanosoma brucei. How-
ever, despite similar abundance in bloodstream form stages, REG9.1 shows differential loca-
tion, being cytoplasmic in slender forms and concentrated at a location close to the flagellar
pocket in stumpy forms. In procyclic forms, the cytoplasmic protein becomes concentrated in
discrete foci upon stress.
Discussion
We have exploited an unbiased genome-wide RNAi selective screen to identify regulators that
repress the expression of transmission stage transcripts in proliferative bloodstream forms of
the African trypanosome. This exploited our previous identification of the ESAG9 family as a
group of stumpy-enriched transcripts, whose protein products are potentially secreted during
the differentiation from stumpy to tsetse midgut procyclic forms [18]. Several outputs from
the selective screen were validated as gene regulators whose gene silencing by RNAi resulted in
Fig 9. Differential cellular location of REG9.1 in the trypanosome life cycle. A. Cellular location of REG9.1 in slender, stumpy and procyclic forms.
Kinetoplast and nuclear DNA was visualised with DAPI staining (pseudocoloured blue), whereas the cell outline was visualised via Phase contrast
microscopy. The REG9.1 signal is cytoplasmic in slender and procylic forms but concentrated at the cell posterior in stumpy forms (arrowed).
Bar = 10μm. B. Co staining of two stumpy cells with REG9.1 (Green), AMCA (Red, staining the flagellar pocket) and propidium iodide (pseudocoloured
Blue, staining the nucleus and kinetoplast). The REG9.1 staining is close to but not coincident with the AMCA staining at the flagellar pocket.
https://doi.org/10.1371/journal.ppat.1006279.g009
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the derepression of the NeoR fused to the 3’UTR of one ESAG9 gene copy. Of these, a predicted
RNA-binding protein, REG9.1, regulated NeoR mRNA and protein levels as well as endoge-
nous ESAG9 transcript levels. Moreover, REG9.1 depletion in pleomorphic trypanosomes
resulted in premature development to the parasite’s transmission stage in vivo, independent of
the parasites normal quorum-sensing response. With overexpression of REG9.1, differentia-
tion of bloodstream form parasites to tsetse midgut procyclic forms was potentiated. Hence
REG9.1 influences the surface architecture of T. brucei, repressing transmission stage tran-
scripts in slender forms and activating the expression of tsetse midgut form transcripts when
expressed at the elevated level typical of procyclic forms. This implicates the molecule as an
important regulator of the parasite’s development and cell surface protein expression, with dif-
ferential effects dependent upon its expression level and life cycle stage.
REG9.1 has been identified in previous global studies investigating the regulation of gene
expression in trypanosomes. For example, the artificial tethering of a REG9.1-lambda-N pep-
tide fusion to a reporter gene 3’UTR bearing a BoxB lambda-N recognition sequence resulted
in reporter gene repression [27, 36] consistent with the repressive effect we observed on
ESAG9 transcripts. Intriguingly, however, we found that the overall abundance of REG9.1 did
not strongly differ between slender and stumpy forms, despite the differential regulation of
transcripts such as ESAG9 between these developmental forms. One explanation for this could
be the evidence for post-translational modification of both the endogenous and ectopically
expressed protein revealed by the migration of distinct isoforms when detected with REG9.1
specific antibody. More obviously, however, the distinct cellular distribution of REG9.1 in slen-
der and stumpy forms could contribute, with the protein being concentrated at a posterior site
in stumpy forms, but not slender or procyclic forms. Hence, sequestration of REG9.1 in
stumpy form cells might alleviate transmission stage mRNAs from repression, with REG9.1
generating its effects through differential location rather than differential abundance in slender
and stumpy forms. Interestingly, other identified regulatory components of stumpy formation
(Tb927.11.6600, Tb927.11.2250) have been found coassociated in stress granules with REG9.1
[12, 34] and we observed a concentration of REG9.1 upon starvation and heat shock in procyc-
lic forms. We suggest this differential location provides a mechanism for regulation via
REG9.1 independent of the protein’s overall abundance, although the nature of the signal con-
centration close to the flagellar pocket awaits further cytological analysis. A posterior concen-
tration of the XRNA stress granule marker near to the posterior location of procyclic form
cells has been described previously [35] but we failed to detect signal when using a XRNA-YFP
fusion cell line, precluding colocalisation analysis with REG9.1. Nonetheless, the cellular distri-
bution reported for XRNA at the cell posterior [35] does not seem quite the same as the flagel-
lar pocket proximal location we observed for REG9.1 in stumpy forms.
The sophistication of gene expression control in trypanosomes is highlighted by the com-
plexity of regulatory signals and regulatory factors that act on distinct transcripts. For ESAG9,
a previous mapping of signals in the 3’UTR that contribute to stumpy-enriched expression
identified a short domain that contributed to expression in stumpy forms, but with more sub-
tle effects in monomorphs [22]. We have confirmed regulatory control via this domain in our
reporter experiments, since deletion of the element resulted in increased NeoR expression and
reduced sensitivity to G418 (S2 Fig). However, REG9.1 regulation of NeoR linked to the ESAG9
3’UTR was not lost upon deletion of this domain, demonstrating that regulation after REG9.1
depletion does not operate through this sequence region alone (S2 Fig). Similarly, a MEME
search (http://meme-suite.org) of transcripts co-regulated with ESAG9 mRNAs in our global
transcriptome analysis identified short motifs enriched in the regulated transcripts distinct
from the previously mapped regulatory element (AUGCGAAUAA and GAAAACAUGC/
GCGUACAUGA), but deletion of these motifs in the ESAG9 3’UTR did not consistently
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increase transcript expression when tested using a NeoR reporter system (S6 Fig). Hence,
the 3’UTR sequences that determine the regulation of ESAG9 when REG9.1 is depleted are
expected to be multifactorial and dispersed. This is consistent with the analysis of 3’UTR regu-
latory signals across several studies where linear motifs have not been detected.
As well as ESAG9, the depletion of REG9.1 in bloodstream forms derepressed two previous
uncharacterised protein families predicted to encode components of the trypanosome cell sur-
face proteome, Family 5 and Family 7. Both of these families, like ESAG9, are T. brucei specific
[21]. The coregulation of Family 5 and Family 7 members with ESAG9 suggests these mole-
cules may have hitherto unexpected roles in the transmission biology of the parasite. Both
have signal peptides for trafficking to the parasite surface and a transmembrane helix [21] and
are of similar size (230–270 amino acids) but otherwise have no recognisable features that
would allow functional assignment in the life cycle. They are also not detected in the proteomic
analyses of stumpy forms and early differentiating cells [17] and therefore these proteins may
not remain cell associated, similar to the extracellular release of ESAG9 members [18]. Intrigu-
ingly, the central coil-coil region of the regulated Family 7 members show some structural sim-
ilarity (http://toolkit.tuebingen.mpg.de/hhpred) to the LRIM1 and APL1C regulators of the
TEP1 complement-like protein in Anopheles mosquitos [37]. It will be interesting to explore
whether these molecules have functional significance in transmission, for example by acting as
countermeasures to arthropod immune factors when stumpy forms enter the tsetse fly.
The transmission biology of trypanosomes remains poorly understood. Nonetheless, the
restriction of ESAG9, Family 5 and Family 7 proteins to T. brucei suggests a function related to
the unique niche that the parasite invades upon entering the fly, or the specific biology of
stumpy forms that are absent in T. congolense and T. vivax. Hence REG9.1may have specialised
to influence the specific surface architecture of the brucei group of African trypanosomes,
including T. b. gambiense and T. b rhodiesiense that cause sleeping sickness in humans, and is
an example of a molecule that maintains the slender form whilst inhibiting progression to
stumpy forms, a so-called ‘slender retainer’ [38]. In contrast, when overexpressed at levels nor-
mally seen in procyclic forms, REG9.1 drove the spontaneous differentiation of bloodstream
forms to procyclic forms in a small proportion of cells, a phenotype opposing two identified
negative regulators of differentiation, TbPTP1[39] and RDK1 [40]. Analysis of the REG9.1
overexpressing bloodstream forms demonstrated they also expressed procyclin on more cells
in the population than uninduced cells when exposed to cis aconitate. This indicated that there
was a higher proportion of differentiation-competent cells (i.e. intermediate or stumpy forms)
after REG9.1 elevation, this being supported by the down regulation of the haptoglobin hae-
moglobin receptor mRNA, a hallmark of intermediate and stumpy forms [41]. PAD1, how-
ever, was not strongly elevated demonstrating that fully developed stumpy forms were not
induced or did not persist prior to differentiation to procyclic forms. A dominant negative
effect of REG9.1 overexpression can also not be excluded as a contributor to the phenotypes
observed although we were careful to ensure expression levels were no higher than those seen
normally in procyclic forms. Overall, our results highlight that the developmental capacity of
trypanosomes can be governed by the expression level of individual regulators, with REG9.1
able to promote differentiation to procyclic forms from the bloodstream in the absence of
external signals, whilst RBP6 [8] is able to promote differentiation between developmental
forms in the tsetse fly.
To date there has been a significant focus on the role of VSG and procyclin as the major
surface proteins of the bloodstream and procyclic forms, respectively. The co-regulation of
ESAG9, Family 5 and Family 7 suggests there is significant further functional complexity to
dissect with respect to the surface interactions of the parasite with its environment during
transmission. The identification of REG9.1 as a global regulator of these surface protein
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families provides a tool to dissect the species-specific tropism of different African trypano-
somes upon transmission and within their tsetse fly vector.
Materials and methods
Ethics statement
Animal experiments in this work were carried out in accordance with the local ethical approval
requirements of the University of Edinburgh and the UK Home Office Animal (Scientific Pro-
cedures) Act (1986) under licence number 60/4373.
Trypanosome culture, constructs and transfection
Monomorphic T. brucei bloodstream form 2T1:T7 [26] and 2T1 cells were used for the RNAi
library screen [42] and for the individual validation of the screen hits, respectively. Pleomor-
phic T. brucei AnTat1.1 90:13 cells [43] were used for the phenotypic analysis of REG9.1 in
bloodstream forms. The 2T1:T7 and 90–13 cell lines express the T7 RNA polymerase and tet-
racycline repressor protein while the 2T1 line lacks the T7 RNA polymerase.
Slender forms were either grown in vitro or harvested from MF1 female mice at 3 days post
infection. Stumpy forms were harvested from cyclophosphamide-treated MF1 female mice at
5 or 6 days post infection. All bloodstream form cell lines were grown in HMI-9 at 37˚C in 5%
CO2. Differentiation of bloodstream to procyclic forms was induced by addition of 6 mM cis-
aconitate and a temperature change from 37˚C to 27˚C. For the phenotypic analysis of REG9.1
in procyclic forms, AnTat1.1 90:13-REG9.1 RNAi cell line was differentiated to procyclic
forms and grown in SDM79 + 50mM N-Acetylglucosamine (GlcNAc) at 27˚C in 5% CO2 [44].
Procyclic 29.13 cell line was used as a control, grown in the same conditions.
The neo-ESAG9 3’UTR reporter cell line and its variations were generated using the p5’neo5’
vector, that contains the neo gene flanked by the aldolase 5’ and 3’UTRs (derived from pbRn,
[45], but with BLE resistance and the rRNA promoter removed). The different bloodstream
form RNAi cell lines were generated using the stem loop vectors pRPa (for monomorphs) [46]
and pALC14 (for pleomorphs)[47], linearized with AscI or NotI respectively, prior to transfec-
tion. RNAi target gene fragments were selected based on default settings of the RNAit software
[48]. Overexpression constructs were generated using a modified pLEW100v5bld-BSD vector
(containing the tagging TY/YFP/TY region derived from pDex577-Y). Monomorph and pro-
cyclic transfections were performed as described by [49]. Pleomorph transfections were done as
described by [50]. Selection was applied by using the appropriate drugs: Geneticin (G418 1 μg/
ml; for p5’neo5’), hygromycin (HYG 2.5 μg/ml; for pRPaiSL), puromycin (PURO 0.5 μg/ml; for
pALC14), blasticidin (BSD 10 μg/ml; for pLEW100v5b1d-BSD) and phleomycin (BLE 1 μg/ml;
for pDex577-Y).
Genome wide selection
2T1:T7 cells were first transfected with pT7Pol.BSD (containing the T7 RNApol and replacing
BLE resistance by BSD) to generate the parental cell line 2T1T7. 2T1T7 was then transfected
with p’5neo5’-ESAG9 3’UTR (Long), where the NEO gene is flanked by 1057nt of the ESAG9-
3’UTR, to generate 2T1T7/E9(Long). These cells were first selected with 1 μg/ml G418 and then
sensitivity to higher doses of the drug was determined for each cell line. 2T1T7/E9(L) was sub-
sequently transfected with pRPaSce and the obtained clones selected after 6 days and tested for
PURO sensitivity (replaced by BLE after transfection). Parasites were finally induced with
1 μg/mL of tetracycline to induce the I-SceI digestion and 3h later 40 μg of the RNAi library
DNA were used to transfect 2x108 cells. 6 h later transfected cells were selected with BLE. Two
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days post-transfection RNAi was induced with 1 μg/ml of tetracycline for 24h and subse-
quently divided in different flasks containing 35x106 cells with different concentrations of
G418 (10 and 25 μg/ml). A control was done with no tetracycline and no G418. After 10–15
days a selected population was obtained and its DNA extracted. Genomic DNA extraction, val-
idation through independent RNAi constructs, Ion Torrent sequencing and bioinformatics
analysis were done as described by [12].
Antibodies and western blotting
Protein samples were boiled for 5 min in Laemmli loading buffer (except PAD1 samples, that
remained unboiled), run in a 10 or 12% SDS/PAGE and transferred to a nitrocellulose mem-
brane. After blocking with 5% milk in PBS-T (0.05% Tween in PBS) for at least 30 min at
room temperature, membranes were incubated with antibodies overnight at 4˚C under agita-
tion in 5% milk in PBS-T. The primary antibodies were used at the following dilutions:
αPAD1 (1:1000); αNeo (1:1000, Neomycin Phosphotransferase II, Merck-Millipore); αEF1α
(1:7000, Elongation Factor 1-alpha, Merck-Millipore); αREG9.1 (1:2500; polyclonal antibody
generated by Eurogentec against the recombinant protein), αBB2 (1:5,[51]). After 3 washes in
PBS-T, two different systems for antibody detection were used. Chemiluminescence required
1h incubation at room temperature with a horseradish peroxidase-conjugated secondary anti-
body in 5% milk (in PBS-T) that was either α-rabbit (1:5000) or α-mouse (1:5000). The mem-
brane was then washed three times in PBS-T and revealed using Pierce ECL2 western blotting
substrate (ThermoScientific). Alternatively, protein was visualised by incubating the mem-
branes for 1h at room temperature with a secondary antibody conjugated to a fluorescent dye
diluted 1:5000 in 50%Odyssey Blocking buffer/50% PBS-T and finally scanning the membrane
with a LI-COR Odyssey imager system.
Northern blotting and transcriptome analysis
For northern blotting, RNA preparation and analysis was carried out as described by [49]. For
the transcriptome analysis, RNA was purified using the RNeasy purification kit (Qiagen) and
sent to BGI Hong Kong. Quality of sequence data provided by BGI was assessed using FastQC
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). No additional processing of the
primary data was required.
Phenotypic analysis
For cell cycle analysis and flow cytometry, cell preparation and analysis was carried out as
described by [12]. Growth curves were generated by analysing typically three independent
flasks of the same cell line grown in parallel (biological replicates) for each clone. Starvation of
procyclic cells was induced by washing the parasites twice in PBS and incubating them for 2h
at 27˚C in PBS. Heat shock was induced by incubating the parasites at 41˚C for 1h. For
REG9.1 localisation, the Sulfo-NHS-AMCA (0.75mM) probe for flagellar pocket staining was
incubated with 4x106 parasites for 10 min at 4˚C and then washed twice with PBS. For immu-
nofluorescence, two different approaches were used depending on the antibody used for the
staining. For cell surface staining, cells were smeared on a glass slide, allowed to dry and fixed
in cold MeOH for 20 min at -20˚C and subsequently rehydrated in PBS. For internal staining
and eYFP visualisation, cells were fixed at RT for 10 min with 4% paraformaldehyde and then
permeabilized with 1% triton for 15 min. In both approaches cells were blocked with 2% BSA
in PBS for 30 min at 37˚C and incubated with either αEP1 1:250 and αVSG221 1:200 or
αREG9.1 1:1000, all in 2% BSA in PBS for 45 min at 37˚C. Then cells were washed twice in
PBS and incubated in αmouse Alexa fluor 488 and αrabbit Alexa fluor 568 or 488, in 2% BSA
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in PBS for 45 min at 37˚C. Subsequently, parasites were stained with either 10 μg/mL DAPI or
Propidium Iodide in PBS and washed twice in PBS. Finally, slides were mounted with Mowiol
containing 2.5% DABCO and analysed on a Zeiss Axio Imager Z2. QCapture was used for
image capture.
Accession numbers
The GEO accession number for the RNA Seq sequence data is GSE81765.
Supporting information
S1 Table. Ion torrent read density for genomic locations across the T. brucei genome after
genome-wide RNAi selection using the long form ESAG9 3’UTR selection construct.
DRBD5, ZFP3 and REG9.1 are highlighted.
(XLSX)
S2 Table. RNA-seq analysis after REG9.1 depletion in pleomorphic cells. Sheet 1 shows the
respective changes in transcript abundance with respect to uninduced cells; other sheets show
the respective log FC change of different transcript families regulated by REG9.1. The regulation
of the Family 2, 5 and 7 surface phylome families is shown on a histogram in chart “Fam charts”.
(XLSX)
S3 Table. RNA-seq analysis after REG9.1 overexpression (through pLew ectopic expres-
sion) in pleomorphic cells. Data availability: Raw data for the data represented in S1, S2 and
S3 Tables is available through the GEO database, with accession reference GSE81765.
(XLSX)
S1 Fig. Validation of individual RNAi lines silencing genes selected in the RNAi library. A.
Northern blots demonstrating the inducible gene silencing of DRBD5 and ZFP3. Two indepen-
dent RNAi clones were analysed for each (DRBD5 clone 1 and 3; ZFP3, clone 1 and 2). B. G418
resistance (at 10μg/ml) of the respective RNAi clones for each target when RNAi were induced
or not. In each case, RNAi results in decreased sensitivity to G418. Two different clones were
used for each growth curve. For each clone, the curve was repeated at least twice (a representa-
tive experiment is shown), each time with three biological replicates. Error bars symbolize
standard deviations of the biological triplicates. C. Northern blot of NeoR transcript levels
when each RNAi line was induced or not; rRNA was used as a loading control. Clone 1 of the
DRBD5 RNAi lines exhibits far higher NeoR RNA than clone 3 for unknown reasons. D. West-
ern blot of NeoR protein when each RNAi line was induced or not; EF1α was used as a loading
control. E. Northern blot of ESAG9 EQ transcript levels when each RNAi line was induced or
not; rRNA was used as a loading control.
(TIF)
S2 Fig. RNAi silencing of REG9.1 in the different reporter cell lines containing different
length 3’UTRs of ESAG9-EQ. A. Reporter constructs with either a short form of the ESAG9
EQ 3’UTR (400nt) or with a previously characterised regulatory element deleted (Δe). B. a
titration of G418 resistance for the NeoR gene flanked by the short form 3’UTR. Cells are less
sensitive to G418 than when the NeoR is flanked by the long form 3’UTR. C., D. Northern blot
of NeoR transcript levels when REG9.1 RNAi was induced or not in each reporter cell line;
NeoR increases after REG9.1 depletion in both short form and mutant reporter cell lines. The
increase in NeoR mRNA is more subtle than in the reporter cell line containing the 1057nt
3’UTR (Fig 2). rRNA was used as a loading control. Two independent RNAi clones were ana-
lysed for each reporter cell line: (2) and (4) for the short (400nt) 3’UTR and (1) and (2) for the
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short mutant (Δe) 3’UTR. For the reporter line with the short form of the ESAG9 3’UTR the
endogenous levels of ESAG9EQ mRNA are also shown, confirming effective elevation of this
transcript when REG9.1 is depleted.
(TIF)
S3 Fig. A. DAPI and Phase contrast images of fields of bloodstream trypanosomes induced,
or not, to silence REG9.1 expression. Parasites are shown on day 3 and day 4 post-infection,
with counterstaining with DAPI to reveal the kinetoplast and nucleus. The morphology of
cells induced or not was equivalent despite the much lower parasitaemia of the induced cells.
B. Cell cycle re-entry of parasites undergoing differentiation in response to cis aconitate. The
profile of G1, and G2/M cells is shown as an average of both REG9.1 RNAi R1 and R2 at 0h, 4h
and 24h after exposure to cis aconitate. Control slender, stumpy and procyclic populations are
also shown, with stumpy cells being arrested in G0/G1. An average of replicates R1 and R2 is
shown, with errors bars symbolizing the standard deviations of both replicates. Analysis was
carried by flow cytometry.
(TIF)
S4 Fig. Ectopic overexpression of REG9.1 potentiates differentiation to procyclic forms.
Bloodstream form parasites are shown 24h after induction of overexpression, with parasites
then being incubated in SDM79+GlcNAC, conditions that allow the continued survival and
proliferation of differentiated procyclic forms. EP procyclin positive cells are detected in
induced populations at low frequency (1–20%) 24 h after induction and accumulate with con-
tinued culture. Uninduced cells in the same conditions show many dead cells although differ-
entiated cells also arise but at lower frequency and only after being in procyclic medium for
144 h.
(TIF)
S5 Fig. A. REG9.1 partially colocalises with Scd6 into cytoplasmic foci after 2h starvation in
procyclic forms. Procyclic forms were starved for 2h in PBS before fixing. Nuclear DNA was
visualised with DAPI staining (in blue). The REG9.1 signal (in red) is distributed along the
cytoplasm in untreated cells and concentrated in foci after starvation in PBS. Some of these
foci co-localise (see arrows) with the stress marker Scd6 fused to YFP (in green). Bar = 10μm.
B. REG9.1. location upon heatshock at 41˚C in procyclic forms. The spot of REG9.1 staining
close to the flagellar pocket is arrowed (a monochrome image is shown since this reveals the
presence of the concentrated signal more clearly).
(TIF)
S6 Fig. Effect of the deletion of identified motifs in the ESAG9 Long 3’UTR of the reporter
construct. A. Schematic representation of the different deletions created in the ESAG9 Long
3’UTR. ΔE1 corresponds to the deletion of the Motif 1. ΔE1+E2 correspond to the deletion of
both Motif 1 and Motif 2. B. Growth of the parasites containing the reporter gene flanked by
the wild type, ΔE1 and ΔE1+E2 Long 3’UTRs of ESAG9 in the presence of different concentra-
tions of G418; the deletion of the different motifs has no effect on the drug resistance.
(TIF)
S1 Supplementary data. (REG9.1 RNAi—DOX): Video of the motility of procyclic forms
not induced to knockdown expression of REG9.1.
(MP4)
S2 Supplementary data. (REG9.1 +DOX) Video of the motility of procyclic forms induced
to knockdown expression of REG9.1.
(MP4)
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